Results 171 to 180 of about 126,819 (310)

Stage I Seminoma of the Testis [PDF]

open access: yes, 1991
Allhoff, E. P.   +4 more
core   +1 more source

Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta‐analysis

open access: yesBJU International, EarlyView.
Objective To evaluate the concordance between clinical complete response (cCR) and pathological complete response (pCR) in muscle‐invasive bladder cancer (MIBC) to assess the surrogacy and prognostic value of cCR for guiding bladder‐sparing strategies.
Navid Roessler   +15 more
wiley   +1 more source

Targeted microwave ablation of localised prostate cancer (VIOLETTE trial): a prospective multicentre study

open access: yesBJU International, EarlyView.
Objective To assess the oncological outcomes of targeted microwave ablation (TMA) using organ‐based tracking (OBT) Fusion® via KOELIS Trinity® (KOELIS, Meylan, France) in men with intermediate‐risk prostate cancer (PCa): the VIOLETTE trial (ClinicalTrials.gov identifier: NCT04582656) Patients and Method In this prospective phase II, multicentre ...
Nicolas Barry Delongchamps   +11 more
wiley   +1 more source

The Effect of Venous Incompetence and Arterial Insufficiency on Erectile Function [PDF]

open access: yes, 1990
Aboseif, Sherif R.   +7 more
core  

New-onset urinary symptoms following marriage leading to discovery of inverted urothelial papilloma in a young female: A case report. [PDF]

open access: yesRadiol Case Rep
Sawafta M   +8 more
europepmc   +1 more source

Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer

open access: yesBJU International, EarlyView.
Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy